Breaking News Instant updates and real-time market news.

FUNC

First United Corp

$13.05 /

-0.41 (-3.05%)

16:01
04/20/20
04/20
16:01
04/20/20
16:01

Driver Management calls for board-level change at First United Corp

Driver Management Company LLC, the manager of an investment partnership that holds more than 5% of the outstanding shares of First United Corporation, has sent a letter to shareholders regarding its nomination of three candidates for election to First United's Board of Directors at the 2020 Annual Meeting of Shareholders on June 11, 2020. Abbott Cooper, Driver's founder and managing member, commented: "Our letter to First United's shareholders should be an eye-opener and make clear once and for all that the current Board is ill-equipped to steward our capital. For too long, First United's boardroom has been marred by cronyism, poor decisions, self-dealing and waste at shareholders' expense. This is why we believe Ms. Rodeheaver's regime has failed to produce enduring value and is now trying to distract from reality by attacking Driver, which has spent the past year championing logical actions that could have de-risked shareholders from a dismal Board and led to meaningful value creation. Fortunately, shareholders have an opportunity at the 2020 Annual Meeting on June 11, 2020 to add sound judgement and necessary oversight to the Board by electing our three highly-qualified, independent nominees, each of whom have no connection to Driver. This is an opportunity to elect three new directors to an underperforming, conflicted eleven-member Board. You can help ensure shareholders have a voice in First United's future, so that history is not repeated coming out of the current crisis created by COVID-19."

TODAY'S FREE FLY STORIES

Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 » 15:51
09/18/20
09/18
15:51
09/18/20
15:51
IWM

iShares Trust Russell 2000 Index Fund

$153.13 /

-0.6 (-0.39%)

, RUT

Russell 2000 Index

$0.00 /

+ (+0.00%)

The Russell 2000 (RUT) is…

The Russell 2000 (RUT) is set to end higher for the week but essentially flat to in line with prior weeks. A range of approximately 1420-1550 has been in place for some time. At the last price of 1535, resistance for the coming week will be in the range of 1550-1600. Support is at 1500-1450. Healthcare, Industrials, and Energy were the standout upside leaders for the week. Communications Services and Utilities finished in the red.

ShowHide Related Items >><<
IWM iShares Trust Russell 2000 Index Fund
$153.13 /

-0.6 (-0.39%)

IWM iShares Trust Russell 2000 Index Fund
$153.13 /

-0.6 (-0.39%)

IWM iShares Trust Russell 2000 Index Fund
$153.13 /

-0.6 (-0.39%)

IWM iShares Trust Russell 2000 Index Fund
$153.13 /

-0.6 (-0.39%)

RUT Russell 2000 Index
$0.00 /

+ (+0.00%)

Periodicals
House Democrats to propose bill for stopgap funding to Dec. 11, Politico says » 15:50
09/18/20
09/18
15:50
09/18/20
15:50
SPY

SPDR S&P 500 ETF Trust

$331.25 /

-3.270776 (-0.98%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

John Bresnahan,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$331.25 /

-3.270776 (-0.98%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$331.25 /

-3.270776 (-0.98%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPX S&P 500
$0.00 /

+ (+0.00%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPY SPDR S&P 500 ETF Trust
$331.25 /

-3.270776 (-0.98%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$331.25 /

-3.270776 (-0.98%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$331.25 /

-3.270776 (-0.98%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$331.25 /

-3.270776 (-0.98%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Hot Stocks
AB InBev partnership with Craft Brew Alliance cleared by DOJ » 15:48
09/18/20
09/18
15:48
09/18/20
15:48
BREW

Craft Brew

$16.27 /

+0.72 (+4.63%)

, BUD

AB InBev

$57.37 /

-0.64 (-1.10%)

Craft Brew Alliance, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BREW Craft Brew
$16.27 /

+0.72 (+4.63%)

BUD AB InBev
$57.37 /

-0.64 (-1.10%)

BREW Craft Brew
$16.27 /

+0.72 (+4.63%)

11/18/19 Cowen
Craft Brew downgraded to Market Perform from Outperform at Cowen
11/12/19 Maxim
Craft Brew downgraded to Hold from Buy at Maxim
09/19/19 MKM Partners
Craft Brew initiated with a Neutral at MKM Partners
BUD AB InBev
$57.37 /

-0.64 (-1.10%)

11:31 Today Barclays
AB InBev price target lowered to EUR 48 from EUR 49 at Barclays
08/19/20 Morgan Stanley
AB InBev price target raised to EUR 42 from EUR 39 at Morgan Stanley
08/18/20 Argus
AB InBev price target raised to $62 from $52 at Argus
07/31/20 RBC Capital
AB InBev price target lowered to EUR 71 from EUR 75 at RBC Capital
BREW Craft Brew
$16.27 /

+0.72 (+4.63%)

BUD AB InBev
$57.37 /

-0.64 (-1.10%)

BREW Craft Brew
$16.27 /

+0.72 (+4.63%)

BUD AB InBev
$57.37 /

-0.64 (-1.10%)

BUD AB InBev
$57.37 /

-0.64 (-1.10%)

BUD AB InBev
$57.37 /

-0.64 (-1.10%)

Technical Analysis
On The Fly: Weekly technical notes for S&P 500 » 15:46
09/18/20
09/18
15:46
09/18/20
15:46
XLK

Technology Select Sector SPDR

$112.27 /

-1.47 (-1.29%)

, XLY

Consumer Discretionary Sector SPDR

$144.17 /

-1.8 (-1.23%)

, XLI

Industrial Select Sector SPDR

$79.14 /

-0.53 (-0.67%)

, XLE

Energy Select Sector SPDR

$33.54 /

-0.455 (-1.34%)

, XLB

S&P Select Materials SPDR

$66.02 /

-0.86 (-1.29%)

, SPY

SPDR S&P 500 ETF Trust

$331.48 /

-3.040776 (-0.91%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

At time of writing the…

At time of writing the S&P 500 (SPX) was set to end down for this week. With price last at 3325, support for the coming week will be in the range of 3300-3250. Resistance will be in the range of 3330-3370. The leading sectors on the downside for the week were Technology (XLK) and Consumer Discretionary (XLY). The leading sectors were the Industrials (XLI), Energy (XLE), and Materials (XLB). The three sectors have been the beneficiaries of rotation from high-flying tech to recovery names.

ShowHide Related Items >><<
XLE Energy Select Sector SPDR
$33.54 /

-0.455 (-1.34%)

SPY SPDR S&P 500 ETF Trust
$331.48 /

-3.040776 (-0.91%)

SPX S&P 500
$0.00 /

+ (+0.00%)

XLK Technology Select Sector SPDR
$112.27 /

-1.47 (-1.29%)

06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
XLY Consumer Discretionary Sector SPDR
$144.17 /

-1.8 (-1.23%)

03/18/20
Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight
XLI Industrial Select Sector SPDR
$79.14 /

-0.53 (-0.67%)

06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
XLE Energy Select Sector SPDR
$33.54 /

-0.455 (-1.34%)

07/06/20 Goldman Sachs
Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs
XLB S&P Select Materials SPDR
$66.02 /

-0.86 (-1.29%)

06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
SPY SPDR S&P 500 ETF Trust
$331.48 /

-3.040776 (-0.91%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPX S&P 500
$0.00 /

+ (+0.00%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPY SPDR S&P 500 ETF Trust
$331.48 /

-3.040776 (-0.91%)

SPX S&P 500
$0.00 /

+ (+0.00%)

XLE Energy Select Sector SPDR
$33.54 /

-0.455 (-1.34%)

SPY SPDR S&P 500 ETF Trust
$331.48 /

-3.040776 (-0.91%)

SPX S&P 500
$0.00 /

+ (+0.00%)

XLK Technology Select Sector SPDR
$112.27 /

-1.47 (-1.29%)

XLY Consumer Discretionary Sector SPDR
$144.17 /

-1.8 (-1.23%)

XLI Industrial Select Sector SPDR
$79.14 /

-0.53 (-0.67%)

XLE Energy Select Sector SPDR
$33.54 /

-0.455 (-1.34%)

SPY SPDR S&P 500 ETF Trust
$331.48 /

-3.040776 (-0.91%)

SPX S&P 500
$0.00 /

+ (+0.00%)

XLK Technology Select Sector SPDR
$112.27 /

-1.47 (-1.29%)

XLY Consumer Discretionary Sector SPDR
$144.17 /

-1.8 (-1.23%)

XLI Industrial Select Sector SPDR
$79.14 /

-0.53 (-0.67%)

XLE Energy Select Sector SPDR
$33.54 /

-0.455 (-1.34%)

XLB S&P Select Materials SPDR
$66.02 /

-0.86 (-1.29%)

SPY SPDR S&P 500 ETF Trust
$331.48 /

-3.040776 (-0.91%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Hot Stocks
Austin Holdco discloses 14.7% Virtusa stake » 15:41
09/18/20
09/18
15:41
09/18/20
15:41
VRTU

Virtusa

$50.40 /

-0.25 (-0.49%)

Austin Holdco disclosed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTU Virtusa
$50.40 /

-0.25 (-0.49%)

VRTU Virtusa
$50.40 /

-0.25 (-0.49%)

09/11/20
Fly Intel: Top five analyst downgrades
09/11/20 Loop Capital
Loop Capital initiates exchanges, market-structure names w/ fintech focus
09/11/20 Loop Capital
Virtusa initiated with a Hold at Loop Capital
09/11/20 Wedbush
Virtusa downgraded to Neutral from Outperform at Wedbush
VRTU Virtusa
$50.40 /

-0.25 (-0.49%)

VRTU Virtusa
$50.40 /

-0.25 (-0.49%)

Recommendations
Amgen sotosarib Phase 1 data a good news/bad news event, says Piper Sandler » 15:39
09/18/20
09/18
15:39
09/18/20
15:39
AMGN

Amgen

$247.45 /

-0.78 (-0.31%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$247.45 /

-0.78 (-0.31%)

AMGN Amgen
$247.45 /

-0.78 (-0.31%)

09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
07/29/20 Piper Sandler
Piper says AbbVie's atogepant 'may yet emerge as best in class'
07/29/20 SVB Leerink
Amgen price target raised to $261 from $253 at SVB Leerink
07/29/20 Wells Fargo
Amgen price target raised to $247 from $237 at Wells Fargo
AMGN Amgen
$247.45 /

-0.78 (-0.31%)

AMGN Amgen
$247.45 /

-0.78 (-0.31%)

AMGN Amgen
$247.45 /

-0.78 (-0.31%)

AMGN Amgen
$247.45 /

-0.78 (-0.31%)

Syndicate
Guardion Health Sciences files $75M mixed securities shelf  15:23
09/18/20
09/18
15:23
09/18/20
15:23
GHSI

Guardion Health Sciences

$0.23 /

+0.0046 (+2.01%)

 
ShowHide Related Items >><<
GHSI Guardion Health Sciences
$0.23 /

+0.0046 (+2.01%)

GHSI Guardion Health Sciences
$0.23 /

+0.0046 (+2.01%)

Technical Analysis
NASDAQ market internals summary » 15:17
09/18/20
09/18
15:17
09/18/20
15:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 15:16
09/18/20
09/18
15:16
09/18/20
15:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
Bio-Path granted patent for p-ethoxy nucleic acids for liposomal formulation » 15:13
09/18/20
09/18
15:13
09/18/20
15:13
BPTH

Bio-Path Holdings

$4.23 /

+0.035 (+0.84%)

Bio-Path Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPTH Bio-Path Holdings
$4.23 /

+0.035 (+0.84%)

BPTH Bio-Path Holdings
$4.23 /

+0.035 (+0.84%)

08/17/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $12 from $18
08/17/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $12 from $18 at H.C. Wainwright
05/18/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $18 from $25 at H.C. Wainwright
BPTH Bio-Path Holdings
$4.23 /

+0.035 (+0.84%)

BPTH Bio-Path Holdings
$4.23 /

+0.035 (+0.84%)

Hot Stocks
Pfizer's treatment for Sickle Cell Disease granted orphan designation » 14:55
09/18/20
09/18
14:55
09/18/20
14:55
PFE

Pfizer

$36.77 /

-0.04 (-0.11%)

Pfizer's treatment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$36.77 /

-0.04 (-0.11%)

PFE Pfizer
$36.77 /

-0.04 (-0.11%)

09/16/20 Baird
uniQure weakness a buying opportunity, says Baird
09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 JMP Securities
Trillium Therapeutics price target raised to $14 from $10 at JMP Securities
PFE Pfizer
$36.77 /

-0.04 (-0.11%)

PFE Pfizer
$36.77 /

-0.04 (-0.11%)

PFE Pfizer
$36.77 /

-0.04 (-0.11%)

PFE Pfizer
$36.77 /

-0.04 (-0.11%)

Hot Stocks
Mustang Bio granted orphan designation by FDA » 14:53
09/18/20
09/18
14:53
09/18/20
14:53
MBIO

Mustang Bio

$3.56 /

-0.03 (-0.84%)

Mustang Bio's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MBIO Mustang Bio
$3.56 /

-0.03 (-0.84%)

MBIO Mustang Bio
$3.56 /

-0.03 (-0.84%)

08/17/20 Oppenheimer
Mustang Bio in position for Priority Review Voucher, says Oppenheimer
08/17/20 H.C. Wainwright
Mustang Bio now on track for priority review voucher, says H.C. Wainwright
02/18/20 H.C. Wainwright
'Not a bad start' for Mustang Bio's MB-106 news, says H.C. Wainwright
01/09/20 Cantor Fitzgerald
Mustang Bio named top pick for 2020 at Cantor Fitzgerald
MBIO Mustang Bio
$3.56 /

-0.03 (-0.84%)

  • 11
    Jun
MBIO Mustang Bio
$3.56 /

-0.03 (-0.84%)

Hot Stocks
Amazon supports DOJ prosecution of defendants charged with fraud » 14:49
09/18/20
09/18
14:49
09/18/20
14:49
AMZN

Amazon.com

$2,935.51 /

-73.16 (-2.43%)

After the United States…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$2,935.51 /

-73.16 (-2.43%)

AMZN Amazon.com
$2,935.51 /

-73.16 (-2.43%)

06:28 Today RBC Capital
Amazon.com's logistics network underappreciated by investors, says RBC Capital
09/16/20 Morgan Stanley
FedEx price target raised to $250 from $110 at Morgan Stanley
09/08/20 Goldman Sachs
Goldman sticks with Sell on Apple despite 71% rally since downgrade
09/03/20 Baird
Amazon working to better handle unprecedented seasonal Q4 demand, says Baird
AMZN Amazon.com
$2,935.51 /

-73.16 (-2.43%)

AMZN Amazon.com
$2,935.51 /

-73.16 (-2.43%)

AMZN Amazon.com
$2,935.51 /

-73.16 (-2.43%)

AMZN Amazon.com
$2,935.51 /

-73.16 (-2.43%)

AMZN Amazon.com
$2,935.51 /

-73.16 (-2.43%)

General news
Minneapolis Federal Reserve Bank President Neel Kashkari Speech to be released at 15:00  14:45
09/18/20
09/18
14:45
09/18/20
14:45
 
Hot Stocks
CDC updates COVID-19 guidance, reinforcing need to test asymptomatic persons » 14:38
09/18/20
09/18
14:38
09/18/20
14:38
QDEL

Quidel

$186.00 /

+15.075 (+8.82%)

, ABT

Abbott

$106.44 /

-0.3 (-0.28%)

, FLDM

Fluidigm

$8.01 /

+0.86 (+12.03%)

, LMNX

Luminex

$24.74 /

-0.02 (-0.08%)

, BDX

Becton Dickinson

$231.28 /

+3.76 (+1.65%)

, FLGT

Fulgent Genetics

$32.47 /

+0.73 (+2.30%)

The Centers for Disease…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QDEL Quidel
$186.00 /

+15.075 (+8.82%)

ABT Abbott
$106.44 /

-0.3 (-0.28%)

FLDM Fluidigm
$8.01 /

+0.86 (+12.03%)

LMNX Luminex
$24.74 /

-0.02 (-0.08%)

BDX Becton Dickinson
$231.28 /

+3.76 (+1.65%)

FLGT Fulgent Genetics
$32.47 /

+0.73 (+2.30%)

QDEL Quidel
$186.00 /

+15.075 (+8.82%)

08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/28/20 Piper Sandler
Quidel pullback on Abbott approval a buying opportunity, says Piper Sandler
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/27/20 Goldman Sachs
Abbott test's sensitivity, low price 'positive surprises,' says Goldman Sachs
ABT Abbott
$106.44 /

-0.3 (-0.28%)

09/11/20 Wolfe Research
Abbott initiated with an Outperform at Wolfe Research
08/31/20 Credit Suisse
Abbott price target raised to $136 from $109 at Credit Suisse
08/28/20 Canaccord
Hospital service channel shares weakness a buying opportunity, says Canaccord
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
FLDM Fluidigm
$8.01 /

+0.86 (+12.03%)

08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/27/20 UBS
Fluidigm price target raised to $16 from $12 at UBS
08/26/20 Piper Sandler
Fluidigm EUA 'de-risks' Covid-19 opportunity, says Piper Sandler
LMNX Luminex
$24.74 /

-0.02 (-0.08%)

08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/18/20 Piper Sandler
Luminex assumed with an Overweight at Piper Sandler
11/11/19 BTIG
Luminex price target lowered to $32 from $37 at BTIG
BDX Becton Dickinson
$231.28 /

+3.76 (+1.65%)

08/27/20 Goldman Sachs
Abbott test's sensitivity, low price 'positive surprises,' says Goldman Sachs
08/27/20 Wells Fargo
Abbott not focused on bringing Covid-19 test to home, says Wells Fargo
08/27/20 Morgan Stanley
Abbott 'may change the game' in COVID testing with BinaxNOW, says Morgan Stanley
08/07/20 Raymond James
Becton Dickinson price target raised to $285 from $265 at Raymond James
FLGT Fulgent Genetics
$32.47 /

+0.73 (+2.30%)

09/03/20 Piper Sandler
Fulgent COVID-19 testing will 'remain robust,' says Piper Sandler
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/20/20
Fly Intel: Top five analyst initiationsNewPage
QDEL Quidel
$186.00 /

+15.075 (+8.82%)

ABT Abbott
$106.44 /

-0.3 (-0.28%)

FLDM Fluidigm
$8.01 /

+0.86 (+12.03%)

LMNX Luminex
$24.74 /

-0.02 (-0.08%)

BDX Becton Dickinson
$231.28 /

+3.76 (+1.65%)

FLGT Fulgent Genetics
$32.47 /

+0.73 (+2.30%)

  • 21
    May
  • 14
    Nov
QDEL Quidel
$186.00 /

+15.075 (+8.82%)

ABT Abbott
$106.44 /

-0.3 (-0.28%)

FLDM Fluidigm
$8.01 /

+0.86 (+12.03%)

LMNX Luminex
$24.74 /

-0.02 (-0.08%)

BDX Becton Dickinson
$231.28 /

+3.76 (+1.65%)

FLGT Fulgent Genetics
$32.47 /

+0.73 (+2.30%)

QDEL Quidel
$186.00 /

+15.075 (+8.82%)

ABT Abbott
$106.44 /

-0.3 (-0.28%)

FLDM Fluidigm
$8.01 /

+0.86 (+12.03%)

LMNX Luminex
$24.74 /

-0.02 (-0.08%)

BDX Becton Dickinson
$231.28 /

+3.76 (+1.65%)

FLGT Fulgent Genetics
$32.47 /

+0.73 (+2.30%)

ABT Abbott
$106.44 /

-0.3 (-0.28%)

FLDM Fluidigm
$8.01 /

+0.86 (+12.03%)

FLGT Fulgent Genetics
$32.47 /

+0.73 (+2.30%)

Hot Stocks
Fluidigm extends rally, up 17% to $8.36 after Citron reiterates $20 target  14:37
09/18/20
09/18
14:37
09/18/20
14:37
FLDM

Fluidigm

$8.07 /

+0.92 (+12.87%)

 
ShowHide Related Items >><<
FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/27/20 UBS
Fluidigm price target raised to $16 from $12 at UBS
08/26/20 Piper Sandler
Fluidigm EUA 'de-risks' Covid-19 opportunity, says Piper Sandler
FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

General news
Treasury Action: the bond market is surprisingly inert and unresponsive » 14:35
09/18/20
09/18
14:35
09/18/20
14:35

Treasury Action: the bond…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
Citron reiterates long position in Fluidigm with $20 price target » 14:33
09/18/20
09/18
14:33
09/18/20
14:33
FLDM

Fluidigm

$8.04 /

+0.885 (+12.38%)

Andrew Left's Citron…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLDM Fluidigm
$8.04 /

+0.885 (+12.38%)

FLDM Fluidigm
$8.04 /

+0.885 (+12.38%)

08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/27/20 UBS
Fluidigm price target raised to $16 from $12 at UBS
08/26/20 Piper Sandler
Fluidigm EUA 'de-risks' Covid-19 opportunity, says Piper Sandler
FLDM Fluidigm
$8.04 /

+0.885 (+12.38%)

FLDM Fluidigm
$8.04 /

+0.885 (+12.38%)

FLDM Fluidigm
$8.04 /

+0.885 (+12.38%)

FLDM Fluidigm
$8.04 /

+0.885 (+12.38%)

Periodicals
JPMorgan to relocate 200 staff as no-deal Brexit looms, Bloomberg reports » 14:33
09/18/20
09/18
14:33
09/18/20
14:33
JPM

JPMorgan

$98.47 /

-0.115 (-0.12%)

JPMorgan has told roughly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JPM JPMorgan
$98.47 /

-0.115 (-0.12%)

JPM JPMorgan
$98.47 /

-0.115 (-0.12%)

09/17/20 RBC Capital
JPMorgan price target raised to $110 from $99 at RBC Capital
09/03/20 Deutsche Bank
JPMorgan upgraded to Buy from Hold at Deutsche Bank
07/24/20
Fly Intel: Top five analyst upgrades
07/24/20 Goldman Sachs
JPMorgan upgraded to Buy from Neutral at Goldman Sachs
JPM JPMorgan
$98.47 /

-0.115 (-0.12%)

JPM JPMorgan
$98.47 /

-0.115 (-0.12%)

JPM JPMorgan
$98.47 /

-0.115 (-0.12%)

JPM JPMorgan
$98.47 /

-0.115 (-0.12%)

Conference/Events
DiaSorin SpA management to meet virtually with Berenberg » 14:33
09/18/20
09/18
14:33
09/18/20
14:33
DSRLF

DiaSorin SpA

$0.00 /

+ (+0.00%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DSRLF DiaSorin SpA
$0.00 /

+ (+0.00%)

DSRLF DiaSorin SpA
$0.00 /

+ (+0.00%)

06/04/20 Berenberg
DiaSorin SpA price target raised to EUR 160 from EUR 145 at Berenberg
05/26/20 Jefferies
DiaSorin SpA downgraded to Underperform from Hold at Jefferies
03/17/20 Berenberg
DiaSorin SpA price target lowered to EUR 110 from EUR 113 at Berenberg
Conference/Events
Carl Zeiss Meditec management to meet virtually with Berenberg » 14:29
09/18/20
09/18
14:29
09/18/20
14:29
CZMWY

Carl Zeiss Meditec

$0.00 /

+ (+0.00%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CZMWY Carl Zeiss Meditec
$0.00 /

+ (+0.00%)

07/17/20 Berenberg
Carl Zeiss Meditec price target raised to EUR 87 from EUR 81 at Berenberg
07/16/20 Deutsche Bank
Carl Zeiss Meditec price target lowered to EUR 110 at Deutsche Bank
05/26/20 Commerzbank
Carl Zeiss Meditec downgraded to Reduce from Hold at Commerzbank
05/12/20 Deutsche Bank
Deutsche Bank backs Buy on Carl Zeiss Meditec after Q2 results
Hot Stocks
LVMH confirms it has submitted Tiffany transaction for approval by EC » 14:28
09/18/20
09/18
14:28
09/18/20
14:28
TIF

Tiffany

$115.24 /

+1.83 (+1.61%)

, LVMUY

LVMH

$0.00 /

+ (+0.00%)

LVMH (LVMUY) confirms…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TIF Tiffany
$115.24 /

+1.83 (+1.61%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$115.24 /

+1.83 (+1.61%)

09/10/20 Wells Fargo
Tiffany price target lowered to $120 from $135 at Wells Fargo
08/25/20 Oppenheimer
Opco 'turning more concerned' LVMH could reduce Tiffany buyout price
06/05/20 Societe Generale
SocGen backs Buy on LVMH after Tiffany statement
06/05/20 Societe Generale
Societe Generale still sees LVMH going through with deal for Tiffany
LVMUY LVMH
$0.00 /

+ (+0.00%)

09/10/20 Societe Generale
LVMH price target raised to EUR 460 from EUR 412 at Societe Generale
09/10/20 Wells Fargo
Tiffany price target lowered to $120 from $135 at Wells Fargo
08/25/20 Oppenheimer
Opco 'turning more concerned' LVMH could reduce Tiffany buyout price
08/18/20 RBC Capital
Estee Lauder price target raised to $194 from $173 at RBC Capital
TIF Tiffany
$115.24 /

+1.83 (+1.61%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$115.24 /

+1.83 (+1.61%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$115.24 /

+1.83 (+1.61%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$115.24 /

+1.83 (+1.61%)

Conference/Events
Spirit Realty management to meet virtually with Berenberg » 14:27
09/18/20
09/18
14:27
09/18/20
14:27
SRC

Spirit Realty

$35.84 /

-0.61 (-1.67%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRC Spirit Realty
$35.84 /

-0.61 (-1.67%)

SRC Spirit Realty
$35.84 /

-0.61 (-1.67%)

08/24/20 BofA
Spirit Realty, Vereit upgraded to Buy from Neutral at BofA
08/24/20 BofA
Spirit Realty upgraded to Buy from Neutral at BofA
06/30/20 Berenberg
Spirit Realty initiated with a Buy at Berenberg
06/29/20 Jefferies
Spirit Realty initiated with a Buy at Jefferies
SRC Spirit Realty
$35.84 /

-0.61 (-1.67%)

  • 09
    Jun
SRC Spirit Realty
$35.84 /

-0.61 (-1.67%)

Options
Fluidigm call volume above normal and directionally bullish » 14:25
09/18/20
09/18
14:25
09/18/20
14:25
FLDM

Fluidigm

$8.07 /

+0.92 (+12.87%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/27/20 UBS
Fluidigm price target raised to $16 from $12 at UBS
08/26/20 Piper Sandler
Fluidigm EUA 'de-risks' Covid-19 opportunity, says Piper Sandler
FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

FLDM Fluidigm
$8.07 /

+0.92 (+12.87%)

Conference/Events
Nikola participates in a conference call with Wedbush » 14:25
09/18/20
09/18
14:25
09/18/20
14:25
NKLA

Nikola

$33.32 /

-0.56 (-1.65%)

Enterprise Software…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKLA Nikola
$33.32 /

-0.56 (-1.65%)

NKLA Nikola
$33.32 /

-0.56 (-1.65%)

09/16/20 JPMorgan
JPMorgan says talks with Nikola CFO 'reassuring'
09/14/20 JPMorgan
Core criticism of Nikola short report 'misconceived,' says JPMorgan
09/14/20 Wedbush
Nikola remains a 'prove me' stock, says Wedbush
09/09/20 RBC Capital
Nikola price target raised to $49 from $46 at RBC Capital
NKLA Nikola
$33.32 /

-0.56 (-1.65%)

NKLA Nikola
$33.32 /

-0.56 (-1.65%)

NKLA Nikola
$33.32 /

-0.56 (-1.65%)

NKLA Nikola
$33.32 /

-0.56 (-1.65%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.